Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soolantra vs Metronidazole in Papulopustular Rosacea (ATTRACT)
NCT01493947Phase 3Completed
- Sponsor
- Galderma
- Start
- Apr 2012
- Primary completion
- Dec 2013
- Countries
- 10
01
Overview
A Phase 3 trial of ivermectin in papulopustular rosacea, sponsored by Galderma. Started Apr 2012; status: completed.
02
Drugs
ivermectin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT01493947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493947.